The rates of patients with resected tissue containing breast carcinoma or DCIS were 21.1% (8 of 38) for ADH, 7.1% (4 of 56) for FEA, and 66.7% (6 of 9) for LN1-2. This evidence concerns the gene AVP and ductal breast carcinoma in situ.